Forbes February 2, 2024
Joshua Cohen

Marijuana is big business these days in the U.S. Revenues could reach $40 billion this year, as the drug is now legal in 37 states for medical purposes while 23 states permit recreational use. However, there’s no federal oversight and an inconsistent, patchy set of state regulations persist.

At the end of last year, President Biden pardoned every American who has used marijuana. This represented a symbolic step toward decriminalizing the drug nationwide. But more importantly, the New York Times reports that in recently disclosed federal government documents scientists are now recommending a rescheduling of marijuana so that it is no longer on par with illicit drugs such as heroin. The researchers suggest imposing fewer restrictions on marijuana, citing studies...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Patient / Consumer, Provider, Regulations
Congressional spending plan: What’s in it for healthcare, and what isn’t
How 3 hospitals are reimagining behavioral crisis care
How Health Systems Can Collaborate on AI Tools
Critical access hospitals face uphill battle: 6 things to know
AdventHealth's plans for new Florida hospital move forward

Share This Article